Summary
Credo Technology Group Holding Ltd (CRDO) reported a significant surge in revenue for the three months ended July 30, 2022, reaching $46.5 million, a 333.3% increase year-over-year, driven primarily by a substantial rise in product sales and a notable increase in IP license revenue. Despite this top-line growth, the company reported a net loss of $73,000 for the quarter, a substantial improvement from the $12.6 million net loss in the prior year period. The company's gross margin also saw significant improvement, expanding to 59.5% from 48.3% in the prior year, benefiting from increased scale in product sales and higher-margin IP license revenue. Operating expenses, particularly in Research and Development and Selling, General & Administrative, increased year-over-year, contributing to the near break-even net loss. The company maintained a strong cash position with $243.8 million in cash and cash equivalents, although net cash used in operating activities was significant at $12.2 million, largely due to working capital changes. Investors should monitor the company's ability to translate its strong revenue growth and improved gross margins into sustainable profitability, while also keeping an eye on the increasing operating expenses and cash burn from operations.
Financial Highlights
45 data points| Revenue | $46.47M |
| Cost of Revenue | $18.80M |
| Gross Profit | $27.66M |
| R&D Expenses | $16.68M |
| SG&A Expenses | $11.20M |
| Operating Expenses | $27.88M |
| Operating Income | -$218K |
| Net Income | -$73K |
| Shares Outstanding (Basic) | 145.08M |
| Shares Outstanding (Diluted) | 145.08M |
Key Highlights
- 1Revenue significantly increased by 333.3% to $46.5 million for the three months ended July 30, 2022, compared to $10.7 million in the prior year period.
- 2Product sales revenue saw a substantial increase of 385.5% to $35.3 million, and IP license revenue grew by 907.8% to $10.4 million.
- 3Net loss improved dramatically to $73,000 from $12.6 million in the prior year, indicating progress towards profitability.
- 4Gross margin expanded significantly to 59.5% from 48.3%, driven by improved operating leverage and a higher contribution from IP license revenue.
- 5Research and Development expenses increased by 72.1% to $16.7 million, and SG&A expenses rose by 57.3% to $11.2 million, reflecting investments in growth and public company costs.
- 6The company maintained a healthy cash balance of $243.8 million as of July 30, 2022.
- 7Net cash used in operating activities was $12.2 million, a substantial outflow driven by working capital changes, particularly increases in accounts receivable and inventories.